Access
To read this story in full you will need to login or make a payment (see right).
2002 in context
Nature 420, 735 (19 December 2002) | doi:10.1038/420735b
Gene therapy: Shining hopes dented — but not dashed
Erika Check
For gene therapists, the news in October that a child in a gene-therapy trial for severe combined immunodeficiency disease (SCID) had developed leukaemia was a devastating blow. The SCID trial, led by Alain Fischer at the Necker Hospital for Sick Children in Paris, was the field's most successful, having cured nine children of this life-threatening illness.
To read this story in full you will need to login or make a payment (see right).